Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2012
11/01/2012WO2012148720A2 Anti-microbial peptides and methods of use thereof
11/01/2012WO2012148547A1 Compositions and methods for treating inflammatory conditions of the ocular surface
11/01/2012WO2012148200A2 Composition for aiding surgical procedures for treating ischemic vascular diseases
11/01/2012WO2012148046A1 Anticancer and cancer-sensitizing composition comprising rrp12 inhibitor
11/01/2012WO2012147933A1 Pharmaceutical composition for treating lysosomal storage disease
11/01/2012WO2012147842A1 Beautiful-skin-promoting agent and use thereof
11/01/2012WO2012147713A1 Anti-b7-h3 antibody
11/01/2012WO2012147470A1 Peptide for inducing regeneration of tissue and use thereof
11/01/2012WO2012146901A1 Novel polypeptides and use thereof
11/01/2012WO2012146773A1 Composition for prevention and treatment of rheumatoid arthritis
11/01/2012WO2012146655A1 Hemostatic compositions
11/01/2012WO2012146651A1 Protein hydrolysates as agents for overcoming addiction
11/01/2012WO2012146625A1 Lyophilized preparation of cytotoxic dipeptides
11/01/2012WO2012146610A1 Composition comprising aflibercept, folinic acid, 5-fluorouracil (5-fu) and irinocetan (folfiri)
11/01/2012WO2012146110A1 Insulin-delivering transdermal formulation and preparation method therefor
11/01/2012WO2012146099A1 Intermediate for synthesizing caspofungin and preparation method therefor
11/01/2012WO2012145908A1 P21 and p21-associated molecules as biomarkers
11/01/2012WO2012145890A1 Use of regulator of calcineurin 1 for manufacturing medicament for treatment of diseases associated with increased nf-κb activity
11/01/2012WO2012122535A3 Stable formulations for parenteral injection of peptide drugs
11/01/2012WO2012121613A3 Meat hydrolysates for food flavoring and medicaments
11/01/2012WO2012120176A3 Recombinant proteins having antitumor effects
11/01/2012WO2012119004A3 Parathyroid hormone analogs, compositions and uses thereof
11/01/2012WO2012110886A4 Controlled-release formulation comprising hcg
11/01/2012WO2012105854A3 Compositions for administration to the eye
11/01/2012WO2012102625A3 Therapeutic composition
11/01/2012WO2012100045A9 Methods of predicting response to jnk inhibitor therapy
11/01/2012WO2012092510A3 Ocular drug delivery system
11/01/2012WO2012087160A3 Anti-inflammatory proteins and methods of preparation and use thereof
11/01/2012WO2012078736A9 Fibrinogen and kidney damage
11/01/2012US20120277623 Methods and Systems of Delivering a Probability of a Medical Condition
11/01/2012US20120277288 Means and Methods for the Specific Modulation of Target Genes in the CNS and the Eye and Methods for Their Identification
11/01/2012US20120277206 Reverse transcriptase inhibitors
11/01/2012US20120277168 Kokumi-imparting agent
11/01/2012US20120277167 Oral formulations of glycyl-2-methylprolyl-glutamate
11/01/2012US20120277166 Conotoxin peptides useful as inhibitors of neuronal amine transporters
11/01/2012US20120277165 Methods of modulating fucosylation of glycoproteins
11/01/2012US20120277164 Gadd45beta targeting agents
11/01/2012US20120277163 MicroRNA-10 Antagonists and MicroRNA-10 Targets for Use in the Treatment of a Glioma
11/01/2012US20120277162 Polypeptide compounds for inhibiting angiogenesis and tumor growth
11/01/2012US20120277161 Inhibition of multiple cell activation pathways
11/01/2012US20120277160 Composition for improving brain function and method for improving brain function
11/01/2012US20120277159 Methods for treating depression using ncam peptide mimetics
11/01/2012US20120277158 Compositions and methods for the transport of therapeutic agents
11/01/2012US20120277157 Disease treatment via antimicrobial peptides or their inhibitors
11/01/2012US20120277156 Inhibition of pathological bone formation
11/01/2012US20120277155 Therapy for kidney disease and/or heart failure
11/01/2012US20120277154 Homodimer of insulinotropic peptide analogues and method for preparation thereof and use thereof
11/01/2012US20120277153 Treating liver diseases
11/01/2012US20120277152 Compressed high density fibrous polymers suitable for implant
11/01/2012US20120277151 Glp-1 pharmaceutical compositions
11/01/2012US20120277150 Novel 3-hydroxyisothiazole 1-oxide derivative
11/01/2012US20120277149 Pharmaceutical combinations for the treatment of metabolic disorders
11/01/2012US20120277148 Insulin analogues with chlorinated amino acids
11/01/2012US20120277147 Prevention of hypoglycaemia in diabetes mellitus type 2 patients
11/01/2012US20120277146 Compounds For Enzyme Inhibition
11/01/2012US20120277145 Compounds
11/01/2012US20120277144 Novel compounds for modulating neovascularisation and methods of treatment using these compounds
11/01/2012US20120277143 IL4/IL13 Binding Repeat Proteins and Uses
11/01/2012US20120277142 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
11/01/2012US20120276192 Compositions and methods for sirna inhibition of icam-1
11/01/2012US20120276182 Methods of treating fungal, yeast and mold infections
11/01/2012US20120276164 Implantable paste and its use
11/01/2012US20120276161 Bioresorbable and biocompatible compounds for surgical use
11/01/2012US20120276152 Systems and methods of using zinc-chelator to treat myocardial infarction
11/01/2012US20120276150 Soft tissue wrap
11/01/2012US20120276149 Methods for modulating bacterial infection
11/01/2012US20120276126 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
11/01/2012US20120276116 Prevention and Treatment of Amyloidogenic Disease
11/01/2012US20120276114 Ifn-gamma inhibitors in the treatment of motoneuron diseases
11/01/2012US20120276107 Methods and Compositions for Mycoplasma Pneumoniae Exotoxins
11/01/2012US20120276087 Methods and compositions using pde4 inhibitors for the treatment and management of autoimmune and inflammatory diseases
11/01/2012US20120276083 Methods for inhibiting ocular angiogenesis
11/01/2012US20120276082 Treatment of cancer
11/01/2012US20120276080 Sheet-like composition
11/01/2012US20120276079 Method of producing recombinant vitamin k dependent proteins
11/01/2012US20120276078 Glycosidase enzymes
11/01/2012US20120276077 Therapeutic ribonucleases
11/01/2012US20120276076 Arf6 as a new target for treating alzheimer's disease
11/01/2012US20120276075 Synergic action of a prolyl protease and tripeptidyl proteases
11/01/2012US20120276074 Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption
11/01/2012US20120276073 Treatment of nerve injuries
11/01/2012US20120276072 Constructs for expressing lysosomal polypeptides
11/01/2012US20120276069 Hydrogels based on polymers of dextran tyramine and tyramine conjugates of natural polymers
11/01/2012US20120276060 Fecal lactoferrin as a biomarker for determining disease severity and for treating infection in patients with clostridium difficile disease
11/01/2012US20120276059 Fecal lactoferrin as a biomarker for determining disease severity and for monitoring infection in patients with clostridium difficile disease
11/01/2012US20120276051 Inhibitors of hepatitis c virus
11/01/2012US20120276050 Methods and compositions of treating a flaviviridae family viral infection
11/01/2012US20120276049 Methods and compositions for amelioration of autoimmune disease using fusion proteins of anti-dendritic cell receptor antibody to peptide sequences
11/01/2012US20120276048 Extended treatment of multiple sclerosis
11/01/2012US20120276047 Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
11/01/2012US20120276046 Anti ganglioside gd3 antibodies and uses thereof
11/01/2012US20120276045 Treatment of solid cancers
11/01/2012US20120276044 Method for inducing migration of adipose-derived adult stem cells
11/01/2012US20120276042 Derivatives of growth hormone and related proteins, and methods of use thereof
11/01/2012US20120276019 Tissue kallikrein for the treatment of parkinson's disease
11/01/2012CA2834657A1 Chemical modification of apolipoprotein mimetic peptides for the production of therapeutic agents
11/01/2012CA2834626A1 Therapeutic nuclease compositions and methods
11/01/2012CA2834624A1 Il4/il13 binding repeat proteins and uses
11/01/2012CA2834516A1 Mfg-e8 and uses thereof
11/01/2012CA2834508A1 Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus
1 ... 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 ... 3163